Percutaneously absorbed NSAIDs attenuate local production of proinflammatory cytokines and suppress the expression of c-Fos in the spinal cord of a rodent model of knee osteoarthritis

Journal of Orthopaedic Science

Volumn 17, Issue 1, 2012, Pages 77-86

  Orita, Sumihisa ^a,b   Ishikawa, Tetsuhiro ^a   Miyagi, Masayuki ^a   Ochiai, Nobuyasu ^a   Inoue, Gen ^a   Eguchi, Yawara ^a   Kamoda, Hiroto ^a   Arai, Gen ^a   Suzuki, Miyako ^a   Sakuma, Yoshihiro ^a   Oikawa, Yasuhiro ^a   Toyone, Tomoaki ^c   Aoki, Yasuchika ^d   Takahashi, Kazuhisa ^a   Ohtori, Seiji ^a  

^a CHIBA UNIVERSITY   (Japan)

^b University of California   (United States)

^c TEIKYO UNIVERSITY   (Japan)

^d TOHO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 6; IODOACETIC ACID; KETOPROFEN; LOXOPROFEN; NERVE GROWTH FACTOR; NONSTEROID ANTIINFLAMMATORY AGENT; PENTOBARBITAL; PROTEIN C FOS; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; JAPAN; KNEE; KNEE OSTEOARTHRITIS; LOW BACK PAIN; NONHUMAN; PATELLA TENDON; PROTEIN EXPRESSION; RANGE OF MOTION; RAT; SPINAL CORD;

EID: 84858860648     PISSN: 09492658     EISSN: 14362023     Source Type: Journal    
DOI: 10.1007/s00776-011-0175-7     Document Type: Article

References (37)

1. Sekiguchi M, Shirasaka M, Konno S, Kikuchi S. Analgesic effect of percutaneously absorbed non-steroidal anti-inflammatory drugs: an experimental study in a rat acute inflammation model. BMC Musculoskelet Dis. 2008;9:1-7.
2. Guingamp C, Gegout-Pottie P, Philippe L, Terlain B, Netter P, Gillet P. Mono-iodoacetate-induced experimental osteoarthritis: a dose-response study of loss of mobility, morphology, and biochemistry. Arthritis Rheum. 1997;40:1670-9. (Pubitemid 27426161)
3. Guzman RE, Evans MG, Bove S, Morenko B, Kilgore K. Monoiodoacetate- induced histologic changes in subchondral bone and articular cartilage of rat femorotibial joints: an animal model of osteoarthritis. Toxicol Pathol. 2003;31:619-24. (Pubitemid 37433471)
4. Bove SE, Calcaterra SL, Brooker RM, Huber CM, Guzman RE, Juneau PL, Schrier DJ, Kilgore KS. Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis. Osteoarthritis Cartilage. 2003;11:821-30. (Pubitemid 37407598)
5. Smith MD, Triantafillou S, Parker A, Youssef PP, Coleman M. Synovial membrane inflammation and cytokine production in patients with early osteoarthritis. J Rheumatol. 1997;24:365-71. (Pubitemid 27104104)
6. Orita S, Ishikawa T, Miyagi M, Ochiai N, Inoue G, Eguchi Y, Kamoda H, Arai G, Toyone T, Aoki Y, Kubo T, Takahashi K, Ohtori S. Pain-related sensory innervation in monoiodoacetateinduced osteoarthritis in rat knees that gradually develops neuronal injury in addition to inflammatory pain. BMC Musculoskelet Disord. 2011;12:134.
7. Hunt SP, Pini A, Evan G. Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature. 1987;328: 632-4. (Pubitemid 17103967)
8. Menétrey D, Gannon A, Levine JD, Basbaum AI. Expression of c-fos protein in interneurons and projection neurons of the rat spinal cord in response to noxious somatic, articular, and visceral stimulation. J Comp Neurol. 1989;285:177-95. (Pubitemid 19186943)
9. Morgan JI, Curran T. Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Annu Rev Neurosci. 1991;14:421-51.
10. Chimoto E, Hagiwara Y, Ando A, Itoi E. Progression of an arthrogenic motion restriction after immobilization in a rat experimental knee model animals. Ups J Med Sci. 2007;112:347-55.
11. Janusz MJ, Bendele AM, Brown KK, Taiwo YO, Hsieh L, Heitmeyer SA. Induction of osteoarthritis in the rat by surgical tear of the meniscus: inhibition of joint damage by a matrix metalloproteinase inhibitor. Osteoarthritis Cartilage. 2002;10:785-91. (Pubitemid 35153719)
12. Schaible HG. Neurophysiology of nociception and pain reactions in inflammatory joint diseases. Rev Rhum Engl Ed. 1997;64:144S-5S.
13. Kunkel SL, Wiggins RC, Chensue SW, Larrick J. Regulation of macrophage tumor necrosis factor production by prostaglandin E2. Biochem Biophys Res Commun. 1986;137:404-10. (Pubitemid 16056080)
14. Tipton DA, Gay DC, DeCoster VA. Effect of a cyclooxygenase-2 inhibitor on interleukin-1beta-stimulated activation of the transcription factor nuclear factor-kappa B in human gingival fibroblasts. J Periodontol. 2007;78:542-9.
15. Kutuk O, Basaga H. Aspirin inhibits TNFalpha- and IL-1-induced NF-kappaB activation and sensitizes HeLa cells to apoptosis. Cytokine. 2004;25:229-37. (Pubitemid 38229414)
16. Ohtori S, Takahashi K, Moriya H, Myers RR. TNF-alpha and TNF-alpha receptor type 1 upregulation in glia and neurons after peripheral nerve injury: studies in murine DRG and spinal cord. Spine. 2004;29:1082-8. (Pubitemid 38649821)
17. 2+ mobilisation and stress kinases in cultured sensory neurones. Neuropharmacol. 2002;42:93-106.
18. Orita S, Koshi T, Mitsuka T, Miyagi M, Inoue G, Arai G, Ishikawa T, Hanaoka E, Yamashita K, Yamashita M, Eguchi Y, Toyone T, Takahashi K, Ohtori S. Associations between proinflammatory cytokines in the synovial fluid and radiographic grading and pain-related scores in 47 consecutive patients with osteoarthritis of the knee. BMC Musculoskelet Dis. 2011;12:144.
19. Lotz M, Guerne PA. Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA). J Biol Chem. 1991;266:2017-20. (Pubitemid 21909022)
20. Iannone F, Bari CD, Accio FD, Covelli M, Patella V, Bianco GL, Lapadula G. Increased expression of nerve growth factor (NGF) and high affinity NGF receptor (p140 TrkA) in human osteoarthritic chondrocytes. Rheumatology (Oxf). 2002;41:1413-8. (Pubitemid 36004319)
21. Pezet S, McMahon SB. Neurotrophins: mediators and modulators of pain. Annu Rev Neurosci. 2006;29:507-38. (Pubitemid 44476854)
22. Manni L, Lundeberg T, Fiorito S, Bonini S, Vigneti E, Aloe L. Nerve growth factor release by human synovial fibroblasts prior to and following exposure to tumor necrosis factor-alpha, interleukin- 1 beta and cholecystokinin-8: the possible role of NGF in the inflammatory response. Clin Exp Rheumatol. 2003;21: 617-24. (Pubitemid 37236456)
23. Carter JL, Lubahn C, Lorton D, Osredkar T, Der TC, Schaller J, Evelsizer S, Flowers S, Ruff N, Reese B, Bellinger DL. Adjuvant- induced arthritis induces c-Fos chronically in neurons in the hippocampus. J Neuroimmunol. 2011;230:85-94.
24. Takayama B, Kikuchi S, Konno S, Sekiguchi M. An immunohistochemical study of the antinociceptive effect of calcitonin in ovariectomized rats. BMC Musculoskelet Dis. 2008;9:164.
25. Abbadie C, Besson JM. c-fos expression in rat lumbar spinal cord during the development of adjuvant-induced arthritis. Neuroscience. 1992;48:985-93.
26. Naranjo JR, Mellström B, Achaval M, Sassone-Corsi P. Molecular pathways of pain: Fos/Jun-mediated activation of a noncanonical AP-1 site in the prodynorphin gene. Neuron. 1991;6: 607-17.
27. Carrive P, Meyer-Carrive I. Changes in formalin-evoked spinal Fos expression and nociceptive behaviour after oral administration of Bufferin A (aspirin) and L-5409709 (ibuprofen + caffeine + paracetamol). Pain. 1997;70:253-66. (Pubitemid 27188581)
28. Honoré P, Buritova J, Besson JM. Carrageenin-evoked c-Fos expression in rat lumbar spinal cord: the effects of indomethacin. Eur J Pharmacol. 1995;272:249-59.
29. Buritova J, Besson JM. Effects of flurbiprofen and its enantiomers on the spinal c-Fos protein expression induced by noxious heat stimuli in the anaesthetized rat. Eur J Pharmacol. 2000;406: 59-67.
30. Delcroix JD, Valletta JS, Wu C, Hunt SJ, Kowal AS, Mobley WC. NGF signaling in sensory neurons: evidence that early endosomes carry NGF retrograde signals. Neuron. 2003;39:69-84. (Pubitemid 36830949)
31. Michael GJ, Averill S, Nitkunan A, Rattray M, Bennett DL, Yan Q, Priestley JV. Nerve growth factor treatment increases brainderived neurotrophic factor selectively in TrkA-expressing dorsal root ganglion cells and in their central terminations within the spinal cord. J Neurosci. 1997;17:8476-90. (Pubitemid 27461069)
32. Kerr BJ, Bradbury EJ, Bennett DL, Trivedi PM, Dassan P, French J, Shelton DB, McMahon SB, Thompson SW. Brain-derived neurotrophic factor modulates nociceptive sensory inputs and NMDA-evoked responses in the rat spinal cord. J Neurosci. 1999;19:5138-48. (Pubitemid 29270149)
33. Orita S, Ohtori S, Nagata M, Horii M, Yamashita M, Yamauchi K, Inoue G, Suzuki M, Eguchi Y, Kamoda H, Arai G, Ishikawa T, Miyagi M, Ochiai N, Kishida S, Takaso M, Aoki Y, Takahashi K. Inhibiting nerve growth factor or its receptors downregulates calcitonin gene-related peptide expression in rat lumbar dorsal root ganglia innervating injured intervertebral discs. J Orthop Res. 2010;28:1614-20.
34. Buritova J, Honoré P, Besson JM. Ketoprofen produces profound inhibition of spinal c-Fos protein expression resulting from an inflammatory stimulus but not from noxious heat. Pain. 1996;67:379-89. (Pubitemid 26375355)
35. Panfil C, Makowska A, Ellrich J. Brainstem and cervical spinal cord Fos immunoreactivity evoked by nerve growth factor injection into neck muscles in mice. Cephalalgia. 2006;26:128-35.
36. Sugimoto M, Kojima T, Asami M, Iizuka Y, Matsuda K. Inhibition of prostaglandin production in the inflammatory tissue by loxoprofen-Na, an anti-inflammatory prodrug. Biochem Pharmacol. 1991;42:2363-8.
37. Ferreira-gomes J, Adães S, Castro-lopes JM. Assessment of movement-evoked pain in osteoarthritis by the knee-bend and catwalk tests: a clinically relevant study. J Pain. 2008;9:945-54.